mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
0.0007 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0009 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |